
























![]()
Cochlear Limited (CHEOY) Q3 2026 Sales/Trading Call April 21, 2026 8:01 PM EDT
Company Participants
Dig Howitt - CEO, MD, President & Executive Director
Conference Call Participants
David Low - UBS Investment Bank, Research Division
Andrew Goodsall - MST Financial Services Pty Limited, Research Division
David Stanton - Jefferies LLC, Research Division
Saul Hadassin - Barrenjoey Markets Pty Limited, Research Division
Chris Cooper - JPMorgan Chase & Co, Research Division
Steven Wheen - Jarden Australia Pty Limited, Research Division
David Bailey - Morgan Stanley, Research Division
Craig Wong-Pan - RBC Capital Markets, Research Division
Sacha Krien - E&P, Research Division
Stuart Welch - Alphinity Investment Management Pty Ltd.
Davinthra Thillainathan - Goldman Sachs Group, Inc., Research Division
Shane Ponraj - Morningstar Inc., Research Division
Presentation
Operator
Thank you for standing by, and welcome to the Cochlear Investor Call. [Operator Instructions]
I would now like to hand the conference over to Mr. Dig Howitt, CEO and President. Please go ahead.
Dig Howitt
CEO, MD, President & Executive Director
Thanks, everyone, for joining on short notice this morning. As I said, we're going to make a few comments to open. What I'd like to do is talk through what are the issues that are impacting the business that have led to a lower sales and lower profit. What are the short-term implications of them for the P&L? And then I think perhaps most importantly, what are the implications for our longer-term strategy and how we implement strategy. So I want to make some comments on each of those, and then we'll open up for questions.
So starting off just with sort of what's happened more recently and what do we see that might be sitting behind that. And I'll start -- talk through each of the segments. I'm going to talk with developed market cochlear implants first and spend most of my time on that
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。